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Abstract
Background: A disease-causing mutation refers to a heritable genetic change that is associated
with a specific phenotype (disease). The detection of a mutation from a patient’s sample is critical
for the diagnosis, treatment, and prognosis of the disease. There are numerous databases and
applications with which to archive mutation data. However, none of them have been implemented
with any automated bioinformatics tools for mutation detection and analysis starting from raw data
materials from patients. We present a Locus Specific mutation DB (LSDB) construction system that
supports both mutation detection and deposition in one package.
Results: COMUS (Clinician-Oriented locus specific MUtation detection and deposition System) is
a mutation detection and deposition system for developing specific LSDBs. COMUS contains 1) a
DNA sequence mutation analysis method for clinicians’ mutation data identification and deposition
and 2) a curation system for variation detection from clinicians’ input data. To embody the COMUS
system and to validate its clinical utility, we have chosen the disease hemophilia as a test database.
A set of data files from bench experiments and clinical information from hemophilia patients were
tested on the LSDB, KoHemGene http://www.kohemgene.org, which has proven to be a clinician-
friendly interface for mutation detection and deposition.
Conclusion: COMUS is a bioinformatics system for detecting and depositing new mutations from
patient DNA with a clinician-friendly interface. LSDBs made using COMUS will promote the clinical
utility of LSDBs. COMUS is available at http://www.comus.info.
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Background
Genetic mutations have two major types: large mutation
(deletion, insertion, duplication, and inversion) and point
mutation (nonsense, missense, and frame shift). Some
mutations can induce DNA transcription and translation
errors eventually causing protein dysfunction that leads
to disease [1,2]. Currently, many whole genome scale
association studies between disease and variation are being
published [3]. However, medical researchers have had to
go through mutations in patient DNA to detect mutations
that may be the cause of a disease [4,5].
There are many human disease gene databases that contain
disease-causing mutation information as locus-specific
databases (LSDBs). Also, large databases, such as Online
Mendelian Inheritance in Man (OMIM) [6] and the
Human Gene Mutation Database (HGMD) [7], collect
and describe comprehensively all disease-related genes. In
contrast, LSDBs usually describe variations in a small
number of genes. The LSDBs aim to provide particular
genetic mutation information for disease-causing genes.
The Human Genome Variation Society (HGVS) has
incorporated information from many LSDBs for rare
human disorders. The key activities of HGVS for LSDB
construction were: 1) collecting mutations and databases
by inviting reviewers of mutations, 2) creating guidelines
for mutation nomenclature, 3) initiating quality control of
LSDB content, and 4) specifying the minimum content of
LSDBs [8].
In order to improve the mutation collection, several
programs were created for an automated LSDB creation.
The UMD (Universal Mutation Database) [9], LOVD
(Leiden Open Variation Database) [10], MuStaR (Muta-
tion Storage and Retrieval) [11], and MUTbase [12] are
major LSDB creation programs and resulting databases.
Curators wishing to construct an LSDB use the programs
according to their specific disease targets. However, these
programs do not support any bioinformatics sequence
analysis method for variation deposition.
Generally, variation detection is achieved with sequencing
patient DNA, the key activity for variation detection.
However, clinicians who study disease-causing mutation
are usually not experts on analyzing sequences. In order to
encourage their data submission to LSDBs, simpler and
more convenient program interface is necessary. We have
developed a simple LSDB construction system that
supports mutation detection and deposition to promote
easier mutation data submission and maintenance http://
www.comus.info.
As a test database, we built a hemophilia disease LSDB. The
disease hemophilia (hemophilia A, HA [MIM #306700];
hemophilia B, HB [#306900]) is one of the most historical
and archetypical Mendelian disorders in human. Patients
with hemophilia suffer from uncontrolled bleeding from
factor VIII or IX deficiency due to a mutation in either the
F8 (HA) or F9 (HB) gene, respectively, on Xq27.1~q28. The
clinical utility of COMUS was validated in this test LSDB,
called KoHemGene http://www.kohemgene.org, using a
set of raw data files from direct sequencing, as well as
clinical information from hemophilia patients.
Methods
Our system consists of a database and web application. The
web application was constructed for mutation candidate
prediction, submission, and registration. Our system was
constructed using the JSP programming language and
MySQL database.
Database structure
The COMUS database tables are classified into five parts:
account, submitted data, registered data, gene information,
and known mutation data from public databases (HGMD,
dbSNP) (Figure 1). For submitted and registered data,
submission IDs and registration IDs are assigned as
reference keys to integrate their related tables. The gene
information part contains gene structure information,
UCSC evolutionary conservation score, and the external
gene ID links. The mutation data part contains known
mutation information from HGMD and dbSNP. This part
is used to define novel mutations from patients.
Predicting mutation candidate
The user can submit data using an AB1 file (chromatogram
files used by instruments from Applied Biosystems) or a
FASTA file as input. When the user inputs an AB1 file, the
web application checks the quality of the sequence and
converts it to FASTA format using the Phred program
[13,14]. After preparing FASTA sequence files, the sequences
are aligned to reference sequences of the gene locus using
the BLAT program [15]. In order to compare patient data
with known sequences, we extracted the genome sequence
and gene structure information from UCSC Hg18 [16].
Input patient sequences are then aligned to reference
genomic regions. After that, we calculate various mutation
types, such as mismatch, insertion, and deletion, as
mutation candidates. In order to define novel mutations,
we compare the genomic positions of mutation candidates
to known variations from public databases. To explore the
evolutionary constraints of mutation candidates, we calcu-
late evolutionary conservation scores using those UCSC
phastCons score [17]. Finally, amino acid changes caused by
each mutation candidate are analyzed.
Submission interface
The user can analyze patients’ sequences using several
additional options. COMUS accepts input files in AB1
BMC Genomics 2009, 10(Suppl 3):S35 http://www.biomedcentral.com/1471-2164/10/S3/S35
Page 2 of 7
(page number not for citation purposes)
and FASTA formats. When a submitter checks the AB1, a
trimming cut-off bar is activated for quality control.
Generally, in order to increase the sequence accuracy, the
user does multiple sequencing runs for the patients’
genomic regions. Therefore, our system is constructed to
support multiple input sequences, and then multiple
alignments are used for predicting mutation candidates.
After the mutation candidate prediction process, the user
can see input sequences, a mutation candidate list, and
an input sequence mapping image against reference gene
DNA sequences. If the user clicks input sequences in
the mapping image, then the detailed alignment
information, a mutation candidate list on the clicked
input sequences, and protein sequences of the input
sequences compared to protein sequences from the gene
can be seen (Figure 2). After the mutation candidate
prediction, the user can select a mutation(s) and add
patient private information for submission.
Figure 1
Database structure. Database tables are classified into five parts: (A) account, (B) submitted data, (C) registered data,
(D) gene information, and (E) known mutation data from public databases (HGMD, dbSNP).
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Figure 2
Report from the mutation candidate prediction system. (A) After query sequence analysis, this mutation candidate
prediction system reports all query sequences, all mutation candidates, and diagrams of target gene locus with query sequence.
In the gene region diagram, the top line represents a gene locus of a target gene, and the blue bar below the top line represents
a mapped query sequence. The next two lines represent mRNAs in the target gene locus. The blue box is UTR regions, and the
red box is coding regions. (B) The detailed information of selected query sequence is shown. The top line represents a gene
locus of a target gene, the red bar represents coding region, the black arrow represents the mapped query sequence, and cyan
boxes are mutation candidates. The mutation candidate table shows mutation type, chromosome position, and the existence
of the mutation candidate in public databases. Nucleotide alignment and protein sequences of the query sequence are shown.
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Curator interface
In order to curate submitted data, we created a curator
account in the web application. Curators can approve any
user’s account (submitter account) and can see all the
submitted sequence data. When the curators register
submitted data, they can use themutation predicting system
to check whether the submitted mutations are appropriate
to deposit into their target LSDB. If the submission is not
appropriate, curators can return the submission with a
return message. With a curator’s approval, the submitted
sequences and mutation are deposited into LSDB.
Results and discussion
We have constructed a mutation candidate detection and
deposition system, COMUS. COMUS addresses two
disadvantages in common LSDB systems such as LOVD
and UMD. First, we incorporated a mutation prediction
system which supports clinicians’ mutation data identi-
fication and submission. Second, COMUS alleviated the
time-consuming bottleneck of specialized curators
maintaining the LSDB systems. Because COMUS makes
it possible to work with an integrated mutation
prediction system, anyone, especially the major varia-
tion detectors who are often clinicians or field workers,
can be curators. To construct a useful LSDB, some
private patient information is necessary. However,
because the specifics of patient information vary
depending on the disease, COMUS supports only
fundamental specifics among patient information:
patient ID, gender, age, country, geographic origin,
Figure 3
Korean registry of hemophilia mutations (KoHemGene). (A) The KoHemGene system collects patient information
using this submission page. (B) The mutation candidate prediction system on the KoHemGene site came from COMUS.
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ethnic origin, disease severity, forced vital capacity
(FVC), motor ability, and comments.
Using the COMUS system, an LSDB for hemophilia
(KoHemGene) was constructed http://www.kohemgene.
org (Figure 3). Using the KoHemGene database, clin-
icians can directly upload raw data files obtained from
sequencing experiments to detect any sequence varia-
tions. Any variation detected is described according to
the HGVS (Human Gene Variation Society) guidelines
and analyzed with reference to relevant databases,
including HGMD. Clinicians can also input clinical
data to link them with genetic information to get
genotype-phenotype correlations.
Recently, Next Generation Sequencing (NGS) technolo-
gies are quickly developing and several complete human
genomes have been sequenced with NGS. However, in
clinics, NGS is not widely used due to difficulty of
processing enormous amounts of data, and the current
high cost of NGS. As Sanger sequencing machines are
still the main facilities in clinics or small-scale wet-labs,
COMUS was constructed focusing on Sanger sequencing
data as input. When the cost of NGS decreases in the
near future, clinicians will use NGS as the method of
patient mutation detection.
Conclusion
COMUS is a comprehensive bioinformatics system that has
been developed to efficiently bridge genetic data from
benchwork to clinics and bedsides. Tailored to have a
clinician-friendly interface, COMUS is believed to promote
the clinical utility of LSDBs and thereby facilitate transla-
tional research in the field of medical genetics, particularly
in terms of genotype-phenotype correlations.
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